Objective To evaluate the clinical application value of the tauro ursodeoxycholic acid (TUDCA) for preventing the relapse of lithiasis after the gallbladder-protected lithotomy.
Methods Totally 80 cholecyslithiasis patients in Chengdu General Military Hospital who met the demand of lithotomy in protecting gallbladder were divided into two groups by random permutations, with 40 patients in each. The calculus was removed by using the percutaneous ultrasonic lithotripsy in order to preserve the well-functioning gallbladder. The patients in the trial group were given TUDCA after surgery for two years, whereas the patients in the control group received the same nursing and diet therapies without medication. The thickness of gallbladder wall and the contraction function of gallbladder were checked two years after surgery, the statistics of the recurrence rate of liary calculus symptoms and cholecyslithiasis were conducted, and the comparison between those two groups was performed.
Results All the operations of gallbladder-protected lithotomy were successful. There was significant difference between those two groups two years after surgery in terms of the thickness of gallbladder wall and the contraction function of gallbladder (P lt;0.05). The relapse of lithiasis was remarkably decreased in the trial group (P lt;0.05).
Conclusion The application of TUDCA for patients with gallbladder-protected lithotomy can prevent the relapse of cholecyslithiasis.
Citation： LUO Zhulin,CHEN Liguo,MIAO Jianguo,YAN Hongtao,REN Jiandong,TIAN Fuzhou. A Clinical Study on Tauro Ursodeoxycholic Acid for the Relapse of Cholelithiasis after Gallbladder-Protected Lithotomy. Chinese Journal of Evidence-Based Medicine, 2011, 11(6): 644-646. doi: 10.7507/1672-2531.20110113 Copy